VC Directory

GROWTH VCs Directory

Curated index of active venture capital funds investing in Europe and Israel. Track partners, stages, and check sizes.

UA1 VC

UA
U

UA1 VC invests in bold founders developing next-generation defense technologies born from Ukraine’s real-world battlefield innovations. The firm focuses on unmanned systems, autonomy, electronic warfare, and advanced manufacturing, aiming to transform these innovations into scalable solutions for NATO and allied nations. UA1 emphasizes long-term partnership, operational support, and strategic introductions to accelerate portfolio companies’ growth beyond Ukraine.

Pre-Seed to Series AEarly-stage defense and dual-use technologies with global scaling potentialleveraging Ukraine’s battlefield-driven innovation ecosystem.

UB FIGG

Helsinki, FI
U

UB FIGG is a pan-European private-equity fund investing in growth companies that develop renewable bio-based materials for packaging, building products and biochemicals.

Growth EquityRenewable bio-based materials

UB Forest Industry Green Growth Fund (UB FIGG)

Helsinki, FI

UB FIGG invests in innovative growth companies accelerating the adoption of renewable bio-based materials, focusing on packaging, building products, and biochemicals to drive climate-positive solutions.

Growth-stage companiesRenewable bio-based materials

UG Investments

Tallinn, EE

UGI invests in Estonian and nearby regional companies, prioritizing sustainability, environmental impact reduction, and responsible business practices. The firm partners closely with management teams to drive growth and long-term value creation in a flexible and agile manner.

Flexible investment horizon, typically supporting early-stage to growth-stage companies with project-specific needsSustainablehigh-potential startups and scale-ups with strong leadership

UK Innovation & Science Seed Fund

EU
U

UKI2S invests in early-stage UK science and technology startups emerging from publicly funded research, driving sustainable growth and societal impact.

Seed+Early-stage startups commercializing publicly funded UK researchparticularly those addressing societal challenges and driving economic growth.

UK Space Agency

Didcot, GB

The UK Space Agency's involvement in investments is driven by a strategy to foster the growth of the UK's space economy and establish a leading position in space-enabled manufacturing. This involves supporting companies pioneering in-orbit manufacturing, such as those developing pharmaceuticals in space, by addressing barriers like regulatory uncertainty and supply chain gaps. The agency aims to facilitate the translation of space-based research into practical applications, contributing to advancements in areas like medicine and semiconductor manufacturing. This investment strategy is underpinned by the belief that microgravity environments can offer unique advantages in manufacturing, leading to higher quality and more effective products. The agency's strategy also includes investing in regional infrastructure through initiatives like the Space Clusters Infrastructure Fund (SCIF). This aims to strengthen regional space economies and build sovereign capabilities in strategically important technologies. By funding projects such as the National Microgravity Research Centre, the agency supports the development of terrestrial facilities that complement space-based manufacturing activities. This hybrid approach, combining in-space manufacturing with ground-based processing and scaling, is designed to accelerate the commercialization of space-derived technologies. Furthermore, the UK Space Agency works collaboratively with other government bodies, such as the Medicines and Healthcare products Regulatory Agency (MHRA), the Regulatory Innovation Office (RIO), and the Civil Aviation Authority (CAA), to create a supportive regulatory environment for space-related industries. This includes providing regulatory guidance, establishing regulatory sandboxes, conducting case studies, and engaging with supply chain stakeholders. By offering regulatory clarity and addressing practical challenges, the agency seeks to encourage innovation and attract investment in the UK space sector. Ultimately, the goal is to ensure that the UK remains at the forefront of space technology and can reap the economic and societal benefits of space exploration and utilization.

Feasibility studies, early-stage companies, infrastructure developmentSpace-enabled manufacturingin-orbit manufacturing of pharmaceuticals

UKRI

GB

UKRI invests over £9 billion annually in public funding to advance knowledge, improve lives, and drive economic growth in the UK. Its focus spans arts, humanities, social sciences, biology, environmental sciences, physics, and engineering through strategic research and innovation initiatives.

Unspecified, but focuses on funding research and innovation across various stages, from curiosity-driven research to translational fundingPublicly funded research and innovation across diverse disciplines

UNEXO

FR

UNEXO is a venture capital firm focused on supporting the development of companies in the Grand Ouest region of France. They offer capital innovation, capital investment, and private debt solutions, indicating a flexible approach to funding different stages and needs. The firm emphasizes its team of experts and their commitment to partnering with ambitious entrepreneurs. They appear to be stage-agnostic, offering support at various key development stages. Their investment approach is designed to cultivate the potential of businesses within their geographic focus.

Multiple stages, including innovation, investment, and debt (implying early to growth stages)Unclear from provided dataneeds further research on portfolio companies and specific areas of expertise of the team

Una Terra

CH

Una Terra invests in early-growth businesses advancing a circular and resilient industrial economy.

Early growthCircular economy and industrial transition

Unifund

EU
U

Uni.Fund invests in research-driven and university-backed startups, focusing on tech solutions that address operational challenges, communication systems, and niche markets like nanotechnology and EdTech. The fund emphasizes startups with strong academic roots and scalable potential.

Early-stage and growth-stage startupsResearch-driven startupsuniversity-backed innovations

Unilever Ventures

GB

Unilever Ventures supports founders building brands aligned with Unilever’s global reach and venture capital agility, emphasizing consumer-centric innovation and scalable growth.

Venture and Growth CapitalForward-thinking founders crafting brands for the modern consumerwith a focus on beauty & wellness

Uniqa Ventures

AT

Uniqa Ventures is not directly mentioned in the crawled pages. The provided content focuses on UNIQA Österreich Versicherungen AG, an Austrian insurance company. The company offers a range of insurance products, including private health insurance, and emphasizes sustainability in its operations. They aim to achieve climate neutrality in Austria by 2040 and in CEE countries by 2050. They operate with a focus on ESG criteria for investments and product development. The company also provides customer service and information through its website and other channels.

Series A and beyond (early growth stage)InsuranceHealthcare

University of Tokyo Innovation Platform (UTokyoIPC)

Tokyo, JP

UTokyo IPC accelerates innovation by bridging academic research and commercialization. It focuses on deep tech startups emerging from the University of Tokyo and other leading institutions, supporting their transition from lab to market through incubation, funding, and hands-on business development. The firm targets transformative technologies in sectors like AI, life sciences, robotics, and sustainability, aiming to solve global challenges such as climate change, healthcare, and energy crises. Its programs, including **1stRound** and **DeepTech Dive**, provide non-dilutive funding, mentorship, and global networking to foster scalable, impact-driven ventures.

Seed to growth-stage (including pre-incorporation, early-stage, and expansion funding).Academia-driven deep tech startupsuniversity-originated innovations

Untitled Investments

U

Untitled Investments is a long-term investor that partners with growth companies in public and private markets.

Growth

Untitled Ventures

GB

the Untitled Ventures specializes in deep tech from Eastern Europe, helping promising startups from Belarus, Russia, and Ukraine scale globally by bridging Eastern and Western Europe.

Early growth stageEarly growth stage technology startups from Eastern Europe

Utrecht Health Seed Fund

Utrecht, NL

Utrecht Holdings Seed Fund (UHSF) invests in science-based startups originating from or closely linked to Utrecht University (UU) and University Medical Centre Utrecht (UMCU). The fund builds upon the success of the UtrechtHealthSeed Fund (UHSF I). Their primary aim is to translate scientific research into broader societal impact by providing early-stage funding to innovative companies. They are committed to supporting ventures that address pressing challenges in healthcare and sustainability, with a focus on creating impactful solutions leveraging cutting-edge research and technologies from UU and UMCU. The fund's investment strategy reflects the research strengths of its investors, primarily focusing on Life Sciences/MedTech, Digital Innovation, and Sustainability. UHSF seeks to bridge the gap between academic research and commercial application by providing crucial seed funding to spin-offs and startups that have demonstrated a clear potential for scalability and positive impact. They are actively looking for opportunities where the innovations are deeply rooted in scientific breakthroughs. The fund invests in companies located in the Netherlands, particularly those connected to the Utrecht ecosystem. They are especially interested in innovations coming from and linked to Utrecht University and University Medical Center Utrecht. The firm intends to foster an environment where early-stage ventures can thrive by providing not only financial backing but also leveraging the vast network, knowledge base, and infrastructure of Utrecht Holdings, Utrecht University and UMCU. The goal is to advance translational science, fostering the growth of innovative businesses and contributing to economic development in the region. UHSF is managed by Utrecht Holdings, the Knowledge Transfer Office of the UU and UMCU, further cementing the alignment with the strategic research priorities and ensuring a close relationship with the source of innovative technologies. The fund seeks to create an ecosystem where academic research can be translated into tangible benefits for society and is actively involved in nurturing and mentoring companies in the early stages. They operate with a collaborative mindset, partnering with other investors and stakeholders to maximize the chances of success for their portfolio companies.

SeedLife Sciences/MedTechDigital Innovation

V-Bio Ventures

Ghent, BE

V-Bio Ventures co-creates startups and invests in early- to mid-stage companies with high growth potential, transforming scientific innovation into products that positively impact people’s lives by leveraging great science and empowering talented entrepreneurs.

Early/midEarly- to mid-stage companies with differentiated technology addressing unmet medical needsfocusing on drug discovery and development

VF Venture (Vækstfonden)

DK

Danmarks Eksport- og Investeringsfond (EIFO) supports Danish companies by providing risk-tolerant financing to drive growth, innovation, and global expansion. The fund focuses on sectors critical to Denmark’s future, including defense and security, green transition, innovative technologies, and international business. EIFO aims to create jobs, boost revenue, and contribute to Denmark’s GDP through strategic investments and financing solutions.

Early-stage startups to large corporatesRisk-tolerant financing for Danish companies to create business opportunities domestically and internationallyfrom early-stage startups to large corporates.

VR Equitypartner

DE

VR Equitypartner provides equity and mezzanine financing to mid-sized companies, including succession, shareholder changes and growth financing.

Nachfolge, Wachstum, GesellschafterwechselMid-sized companies; successionshareholder changes and growth financing

Vaaka Partners

Helsinki, FI

Vaaka Partners focuses on supporting business masters by emphasizing honesty, growth, and collaboration. They prioritize transparency, flexibility, and patience in helping companies achieve mastery in their industries through active participation and teamwork.

GrowthGrowth-stage Finnish companies

Valo Ventures

US

Valo Ventures focuses on solving the world's most pressing problems by investing in innovative companies that leverage data-centric technologies, emerging energy solutions, and adaptive strategies to address climate change and resource constraints.

Early-stage to growth-stage companiesValo Ventures invests in companies that reduce frictionoptimize planning

Vargas Holding

SE

Vargas invests in high-impact ventures disrupting hard-to-abate industries by combining innovation, technology, and capital to accelerate electrification and decarbonization. The firm supports greenfield startups from inception and acts as an active long-term owner as they scale.

Early-stage to growth-stage (greenfield ventures and scaling impact companies)Electrification and decarbonization in high-emission industries

Venionaire Capital

Vienna, AT

Venionaire Capital partners with investors, entrepreneurs, and corporates to drive transformational change through venture capital, private equity, and corporate finance solutions. They focus on global synergies, entrepreneurial support, and data-driven insights to enable growth, M&A, and fund structuring across continents. Their initiatives like the European Super Angels Club (ESAC) and World Venture Forum foster innovation and investment ecosystems.

Early-stage to growth-stage (via European Super Angels Club) and corporate M&A/restructuringEarly-stage startupshigh-growth European ventures

Vensana Capital

Newport Beach, US

Vensana Capital is a venture capital and growth equity investment firm focused exclusively on the medical technology sector. They partner with entrepreneurs who are developing breakthrough innovations to transform healthcare. The firm invests in development and commercial stage companies across the medtech spectrum. Their goal is to provide capital and commitment to amplify the success of experienced, insightful, and bold management teams. Vensana places a high value on partnership, seeking to champion their entrepreneurs and provide them with the resources and support they need to succeed.

Development and commercial stageMedical devicesdiagnostics and data science